JP2022513173A5 - - Google Patents

Info

Publication number
JP2022513173A5
JP2022513173A5 JP2021531204A JP2021531204A JP2022513173A5 JP 2022513173 A5 JP2022513173 A5 JP 2022513173A5 JP 2021531204 A JP2021531204 A JP 2021531204A JP 2021531204 A JP2021531204 A JP 2021531204A JP 2022513173 A5 JP2022513173 A5 JP 2022513173A5
Authority
JP
Japan
Prior art keywords
sequence
patient
threshold
reactions
mutations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021531204A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022513173A (ja
JP7407193B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/056625 external-priority patent/WO2020031048A1/en
Publication of JP2022513173A publication Critical patent/JP2022513173A/ja
Publication of JP2022513173A5 publication Critical patent/JP2022513173A5/ja
Application granted granted Critical
Publication of JP7407193B2 publication Critical patent/JP7407193B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021531204A 2018-08-08 2019-08-02 可変の複製多重ｐｃｒを使用した配列決定方法 Active JP7407193B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862716082P 2018-08-08 2018-08-08
US62/716,082 2018-08-08
PCT/IB2019/056625 WO2020031048A1 (en) 2018-08-08 2019-08-02 Method of sequencing using variable replicate multiplex pcr

Publications (3)

Publication Number Publication Date
JP2022513173A JP2022513173A (ja) 2022-02-07
JP2022513173A5 true JP2022513173A5 (enExample) 2022-07-29
JP7407193B2 JP7407193B2 (ja) 2023-12-28

Family

ID=67953830

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021531204A Active JP7407193B2 (ja) 2018-08-08 2019-08-02 可変の複製多重ｐｃｒを使用した配列決定方法

Country Status (9)

Country Link
US (4) US11566274B2 (enExample)
EP (1) EP3833783B1 (enExample)
JP (1) JP7407193B2 (enExample)
KR (1) KR102910949B1 (enExample)
CN (1) CN112601824A (enExample)
AU (1) AU2019319711B2 (enExample)
BR (1) BR112021002189A2 (enExample)
CA (1) CA3107376A1 (enExample)
WO (1) WO2020031048A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105190656B (zh) 2013-01-17 2018-01-16 佩索纳里斯公司 用于遗传分析的方法和系统
US10125399B2 (en) 2014-10-30 2018-11-13 Personalis, Inc. Methods for using mosaicism in nucleic acids sampled distal to their origin
US11299783B2 (en) 2016-05-27 2022-04-12 Personalis, Inc. Methods and systems for genetic analysis
JP7407193B2 (ja) 2018-08-08 2023-12-28 イニヴァータ リミテッド 可変の複製多重ｐｃｒを使用した配列決定方法
JP7470787B2 (ja) 2019-11-05 2024-04-18 パーソナリス，インコーポレイティド 単一試料からの腫瘍純度の推定
WO2023012521A1 (en) * 2021-08-05 2023-02-09 Inivata Limited Highly sensitive method for detecting cancer dna in a sample
JP2023536325A (ja) * 2020-08-05 2023-08-24 イニヴァータ リミテッド 試料中のがんｄｎａを検出するための高感度の方法
WO2023059654A1 (en) 2021-10-05 2023-04-13 Personalis, Inc. Customized assays for personalized cancer monitoring
EP4652604A1 (en) 2023-01-18 2025-11-26 Inivata Ltd. Cancer-associated genetic variant filtering using mutational signatures
WO2026006629A1 (en) 2024-06-27 2026-01-02 Personalis, Inc. System and method for management of compressed sequencing files

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948902A (en) 1997-11-20 1999-09-07 South Alabama Medical Science Foundation Antisense oligonucleotides to human serine/threonine protein phosphatase genes
US7727720B2 (en) 2002-05-08 2010-06-01 Ravgen, Inc. Methods for detection of genetic disorders
US20040086892A1 (en) 2002-11-06 2004-05-06 Crothers Donald M. Universal tag assay
US20050233340A1 (en) 2004-04-20 2005-10-20 Barrett Michael T Methods and compositions for assessing CpG methylation
US20060263789A1 (en) 2005-05-19 2006-11-23 Robert Kincaid Unique identifiers for indicating properties associated with entities to which they are attached, and methods for using
US20070020640A1 (en) 2005-07-21 2007-01-25 Mccloskey Megan L Molecular encoding of nucleic acid templates for PCR and other forms of sequence analysis
US20070068573A1 (en) 2005-08-22 2007-03-29 Applera Corporation Device and method for microfluidic control of a first fluid in contact with a second fluid, wherein the first and second fluids are immiscible
WO2007133710A2 (en) 2006-05-11 2007-11-22 Raindance Technologies, Inc. Microfluidic devices and methods of use thereof
AU2008255569A1 (en) 2007-06-01 2008-12-04 Monoquant Pty Ltd A method for DNA breakpoint analysis
US20110230372A1 (en) * 2008-11-14 2011-09-22 Stc Unm Gene expression classifiers for relapse free survival and minimal residual disease improve risk classification and outcome prediction in pediatric b-precursor acute lymphoblastic leukemia
US9524369B2 (en) 2009-06-15 2016-12-20 Complete Genomics, Inc. Processing and analysis of complex nucleic acid sequence data
WO2011140187A2 (en) 2010-05-04 2011-11-10 University Of Rochester Detecting chromosomal rearrangement
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
EP3225697A3 (en) * 2010-12-30 2017-11-22 Foundation Medicine, Inc. Optimization of multigene analysis of tumor samples
HK1199745A1 (en) 2011-09-09 2015-07-17 The Board Of Trustees Of The Leland Stanford Junior University Methods for obtaining a sequence
AU2012385961B9 (en) 2012-07-24 2017-05-18 Natera, Inc. Highly multiplex PCR methods and compositions
GB201301857D0 (en) 2013-02-01 2013-03-20 Selvi Ozan Method
CN105102635B (zh) 2013-03-15 2020-09-25 生命技术公司 肺癌的分类和可行性指数
US20160032396A1 (en) 2013-03-15 2016-02-04 The Board Of Trustees Of The Leland Stanford Junior University Identification and Use of Circulating Nucleic Acid Tumor Markers
US10262755B2 (en) 2014-04-21 2019-04-16 Natera, Inc. Detecting cancer mutations and aneuploidy in chromosomal segments
EP3071706B1 (en) 2013-11-21 2018-04-25 Assistance Publique-Hôpitaux de Paris Method for detecting chromosomal rearrangements
CN111534580B (zh) 2013-12-28 2024-06-04 夸登特健康公司 用于检测遗传变异的方法和系统
GB201412834D0 (en) 2014-07-18 2014-09-03 Cancer Rec Tech Ltd A method for detecting a genetic variant
CN107002123A (zh) * 2014-08-14 2017-08-01 生命技术公司 多重转录组分析
US20170283854A1 (en) 2014-09-05 2017-10-05 University Of Florida Research Foundation, Inc. Multiplexed pcr assay for high throughput genotyping
US11149305B2 (en) * 2015-01-23 2021-10-19 Washington University Detection of rare sequence variants, methods and compositions therefor
US20160275240A1 (en) 2015-02-18 2016-09-22 Nugen Technologies, Inc. Methods and compositions for pooling amplification primers
WO2016201142A1 (en) 2015-06-09 2016-12-15 Life Technologies Corporation Methods, systems, compositions, kits, apparatus and computer-readable media for molecular tagging
AU2016363113A1 (en) 2015-12-03 2018-06-07 Alfred Health Monitoring treatment or progression of myeloma
CN106282356B (zh) * 2016-08-30 2019-11-26 天津诺禾医学检验所有限公司 一种基于扩增子二代测序点突变检测的方法及装置
GB201615486D0 (en) 2016-09-13 2016-10-26 Inivata Ltd Methods for labelling nucleic acids
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
CN106834275A (zh) * 2017-02-22 2017-06-13 天津诺禾医学检验所有限公司 ctDNA超低频突变检测文库的构建方法、试剂盒及文库检测数据的分析方法
GB201709675D0 (en) 2017-06-16 2017-08-02 Inivata Ltd Method for detecting genomic rearrangements
WO2019043059A1 (en) 2017-08-30 2019-03-07 Symphogen A/S COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER BY ANTI-EGFR ANTIBODIES
EP3682035B1 (en) * 2017-09-15 2025-02-05 The Regents of the University of California Detecting somatic single nucleotide variants from cell-free nucleic acid with application to minimal residual disease monitoring
EP3704268B1 (en) 2017-11-03 2025-01-22 Guardant Health, Inc. Normalizing tumor mutation burden
WO2019099750A1 (en) 2017-11-17 2019-05-23 Research Cancer Institute Of America Compositions, methods, systems and/or kits for preventing and/or treating neoplasms
GB201804641D0 (en) 2018-03-22 2018-05-09 Inivata Ltd Methods of sequencing nucleic acids and error correction of sequence reads
GB201804642D0 (en) 2018-03-22 2018-05-09 Inivata Ltd Methods of labelling nucleic acids
EP3784805A1 (en) 2018-04-23 2021-03-03 Inivata Limited Method for predicting and monitoring response to an immune checkpoint inhibitor
US20210040564A1 (en) 2018-04-23 2021-02-11 Inivata Ltd. Method for predicting and monitoring response to an immune checkpoint inhibitor
US10329627B1 (en) 2018-04-23 2019-06-25 Inivata Ltd. Method for predicting and monitoring response to an immune checkpoint inhibitor
JP7407193B2 (ja) 2018-08-08 2023-12-28 イニヴァータ リミテッド 可変の複製多重ｐｃｒを使用した配列決定方法
US11377698B2 (en) 2018-09-05 2022-07-05 Inivata Ltd. Method of treating a cancer patient without the need for a tissue biopsy
EP4219763A3 (en) 2018-12-12 2023-08-16 Inivata Ltd. Method for quantifying gene fusion dna
US10533214B2 (en) 2018-12-21 2020-01-14 Inivata Ltd. Method for measuring mutational load
WO2020174406A1 (en) 2019-02-28 2020-09-03 Inivata Ltd. Method for quantifying the amount of a target sequence in a nucleic acid sample
WO2021028768A1 (en) 2019-08-13 2021-02-18 Inivata Ltd. METHOD FOR ALTERING THERAPY OF ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS BASED ON ANALYSIS OF ctDNA
JP2023536325A (ja) 2020-08-05 2023-08-24 イニヴァータ リミテッド 試料中のがんｄｎａを検出するための高感度の方法

Similar Documents

Publication Publication Date Title
Wright et al. Beyond the consensus: dissecting within-host viral population diversity of foot-and-mouth disease virus by using next-generation genome sequencing
JP5926183B2 (ja) 疾患関連ｋｉｒハプロタイプの決定
US11155872B2 (en) Detection and quantification of donor cell-free DNA in the circulation of organ transplant recipients
US11162094B2 (en) Capture methodologies for circulating cell free DNA
US9181591B2 (en) Quantification of adaptive immune cell genomes in a complex mixture of cells
JP7407193B2 (ja) 可変の複製多重ｐｃｒを使用した配列決定方法
EP3607065B1 (en) Method and kit for constructing nucleic acid library
EP3132059A2 (en) Quantification of adaptive immune cell genomes in a complex mixture of cells
JP2021526791A5 (enExample)
JP2023536325A (ja) 試料中のがんｄｎａを検出するための高感度の方法
CA3176541A1 (en) Single step sample preparation for next generation sequencing
US20180291369A1 (en) Error-proof nucleic acid library construction method and kit
KR102187429B1 (ko) 목표 유전자를 검출하기 위한 프라이머의 설계 방법
Zhang et al. COG6‐CDG: Two Novel Variants and Milder Phenotype in a Chinese Patient
JP6905235B1 (ja) ＳＡＲＳ−ＣｏＶ−２検出用プライマーセット、ＳＡＲＳ−ＣｏＶ−２を検査するための方法、ＳＡＲＳ−ＣｏＶ−２の検査試薬および検査キット
Seshasubramanian et al. Application of high‐throughput next‐generation sequencing for HLA typing of DNA extracted from postprocessing cord blood units
JP2017500886A (ja) Ｈｃｖ遺伝子型決定アルゴリズム
US20210115435A1 (en) Error-proof nucleic acid library construction method
CA3185142A1 (en) Methods of identifying markers of graft rejection
EP4573214B1 (en) Nucleic acid amplification
CN110846395A (zh) 一种检测肺动脉高压病的kcnk3基因探针组及其应用
CN120536570B (zh) 一种检测人非5q型脊髓性肌萎缩症基因的引物组及其方法和应用
US20230054019A1 (en) Calculation method for base methylation degree and program
Liharska Identification of Molecular Relationships Between Living and Postmortem Brain Tissue
TWI403587B (zh) 特定群核酸序列組合之最小群多用引子及特異群雙重探針及其鑑別檢測應用方法